Publication helps establish the efficacy and safety profile of of CTx-1301, reinforcing the potential of Cingulate’s Precision Timed Release™ platform technology ...

Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced ...

(NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small ...

A six-month trial found that older women who ate within eight to nine hours daily showed cognitive improvements beyond what ...

To eat healthy, I follow some simple rules. I eat a lot of fruits, vegetables, beans and fiber-rich plants. I eat lean ...

In June, Brazils ANVISA released a batch of clinical trial petitions because its review deadline had expired without a ...

Kyverna Therapeutics stays a Strong Buy as miv-cel advances in SPS, gMG & refractory RA; BLA by Q4 2026 and key trial ...

Zohran Mamdani did not rule out cash reparations for Black New Yorkers when pressed during an interview, saying he awaits the ...

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that The Lancet has published full results of its ADVANCE OUTCOMES study, available here. Ralinepag has ...

Discusses FDA Feedback on PMA Supplement for Indication Expansion into Idiopathic Generalized Epilepsy July 28, 2026 4:30 ...

Federal agents are arresting spouses of Americans, tech workers and others whose visas have expired, including many who have ...

The study was a six month clinical trial and its findings were presented at NUTRITION 2026, the annual meeting of the ...